Kodiak Sciences (KOD) Current Leases (2019 - 2026)
Kodiak Sciences' (KOD) quarterly Current Leases came in at $11.7 million in Q1 2026, up 6.5% YoY from $10.9 million in Q1 2025, and down 3.34% on a QoQ basis from $12.1 million in Q4 2025.
Kodiak Sciences (KOD) Current Leases (2019 - 2026) Analysis & Trends
Kodiak Sciences (KOD) has 8 years of Current Leases data on file, last reported at $11.7 million in Q1 2026.
- Quarterly Current Leases rose 6.5% year-over-year to $11.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.7 million (up 6.5% YoY) and the FY2025 annual result came in at $12.1 million, up 13.5% from the prior year.
- Current Leases fell to $11.7 million in Q1 2026, from $12.1 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $12.1 million in Q4 2025 to a low of $5.0 million in Q1 2022.
- A 5-year average of $9.6 million and a median of $9.9 million in 2024 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2022 — Current Leases soared 463.8% — and 2023, when it dropped 1.57%.
- Tracing KOD's Current Leases over 5 years: stood at $9.9 million in 2022, then dropped by 1.57% to $9.8 million in 2023, then rose by 8.78% to $10.6 million in 2024, then gained by 13.5% to $12.1 million in 2025, then fell by 3.34% to $11.7 million in 2026.
- The last three Current Leases figures came in at $11.7 million (Q1 2026), $12.1 million (Q4 2025), and $11.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Kodiak Sciences | 2.60 Bn | 2.60 Bn | - | 9.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.81 Mn |
| Mar 31, 2026 | 11.66 Mn |
| Dec 31, 2025 | 12.06 Mn |
| Sep 30, 2025 | 11.75 Mn |
| Jun 30, 2025 | 11.29 Mn |
| Mar 31, 2025 | 10.95 Mn |
| Dec 31, 2024 | 10.63 Mn |
| Sep 30, 2024 | 10.20 Mn |
| Jun 30, 2024 | 9.89 Mn |
| Mar 31, 2024 | 9.61 Mn |
| Dec 31, 2023 | 9.77 Mn |
| Sep 30, 2023 | 9.02 Mn |
| Jun 30, 2023 | 7.85 Mn |
| Mar 31, 2023 | 7.94 Mn |
| Dec 31, 2022 | 9.93 Mn |
| Sep 30, 2022 | 9.13 Mn |
| Jun 30, 2022 | 6.04 Mn |
| Mar 31, 2022 | 4.98 Mn |
| Dec 31, 2021 | 3.93 Mn |
| Sep 30, 2021 | 1.62 Mn |